ISSN: 2155-6148
Tajera Tageza Ilala*, Fentaw Belay Muhammed, Dugo Angasa Daba, Gudeta Teku Ayano and Megersa Kelbesa Olika
Recently, the need for cesarean section is enormously increasing and increasing, addressing the concern of anesthesia for cesarean section in a similar manner. Physiologic changes during pregnancy such as increased cardiac out, heart rate, and oxygen consumption, decreased lung compliance and capacity, a shift away from cell-mediated immunity, and increased risk of thromboembolic disease reduce maternal compensation during stress and certain pathological conditions like infections. Importantly, the provision of anesthesia for a pregnant mother is perceived as a challenging situation, because of the attending physiological, anatomical, and pharmacological changes of pregnancy. This culminates in the modification and dosage adjustment for certain medications specially sedative-hypnotics and delivery as well as management of anesthetic techniques, in the pace of optimizing and ensuring maternal organ function and fetal well-being.
Certain perioperative factors such as COVID-19 infection, comorbid disease and obstetrics complications increase the risk of maternal morbidity and mortality with a subsequent fetal compromise during the perioperative state, besides the aforementioned anesthetic challenges. Moreover, COVID-19 infection increases the perils of complicating pregnancy and pregnancy outcomes including maternal artificial ventilation and intensive care admission, preterm labor, fetal distress, neonatal intensive care admission, fetal and maternal death. Preventive strategies toward the spread of COVID-19 infection, vaccines, and the proper use of personnel protective equipment by health care providers reduce the spread and severity of COVID-19 infection and improve the obstetrics and pregnancy outcomes.
Published Date: 2022-11-05; Received Date: 2022-10-03